244 related articles for article (PubMed ID: 32543669)
1. International prescribing patterns and polypharmacy in older people with advanced chronic kidney disease: results from the European Quality study.
Hayward S; Hole B; Denholm R; Duncan P; Morris JE; Fraser SDS; Payne RA; Roderick P; Chesnaye NC; Wanner C; Drechsler C; Postorino M; Porto G; Szymczak M; Evans M; Dekker FW; Jager KJ; Caskey FJ;
Nephrol Dial Transplant; 2021 Feb; 36(3):503-511. PubMed ID: 32543669
[TBL] [Abstract][Full Text] [Related]
2. Polypharmacy and potentially inappropriate prescribing of benzodiazepines in older nursing home residents.
Kummer I; Reissigová J; Lukačišinová A; Ortner Hadžiabdić M; Stuhec M; Liperoti R; Finne-Soveri H; Onder G; van Hout H; Fialová D
Ann Med; 2024 Dec; 56(1):2357232. PubMed ID: 38833339
[TBL] [Abstract][Full Text] [Related]
3. Any versus long-term prescribing of high risk medications in older people using 2012 Beers Criteria: results from three cross-sectional samples of primary care records for 2003/4, 2007/8 and 2011/12.
Ble A; Masoli JA; Barry HE; Winder RE; Tavakoly B; Henley WE; Kuchel GA; Valderas JM; Melzer D; Richards SH
BMC Geriatr; 2015 Nov; 15():146. PubMed ID: 26542116
[TBL] [Abstract][Full Text] [Related]
4. Polytherapy and the risk of potentially inappropriate prescriptions (PIPs) among elderly and very elderly patients in three different settings (hospital, community, long-term care facilities) of the Friuli Venezia Giulia region, Italy: are the very elderly at higher risk of PIPs?
Cojutti P; Arnoldo L; Cattani G; Brusaferro S; Pea F
Pharmacoepidemiol Drug Saf; 2016 Sep; 25(9):1070-8. PubMed ID: 27184012
[TBL] [Abstract][Full Text] [Related]
5. Polypharmacy is a risk factor for mortality, severe chronic kidney disease, and liver disease among privately insured adults with cerebral palsy.
Whitney DG; Schmidt M; Haapala H
J Manag Care Spec Pharm; 2021 Jan; 27(1):51-63. PubMed ID: 33377441
[No Abstract] [Full Text] [Related]
6. Inter-practice variation in polypharmacy prevalence amongst older patients in primary care.
Sinnige J; Braspenning JC; Schellevis FG; Hek K; Stirbu I; Westert GP; Korevaar JC
Pharmacoepidemiol Drug Saf; 2016 Sep; 25(9):1033-41. PubMed ID: 27133740
[TBL] [Abstract][Full Text] [Related]
7. Prescribing patterns and predictors of high-level polypharmacy in the elderly population: A prospective surveillance study from two teaching hospitals in India.
Harugeri A; Joseph J; Parthasarathi G; Ramesh M; Guido S
Am J Geriatr Pharmacother; 2010 Jun; 8(3):271-80. PubMed ID: 20624616
[TBL] [Abstract][Full Text] [Related]
8. Potentially inappropriate prescribing in older adults with advanced chronic kidney disease.
Molnar AO; Bota S; Jeyakumar N; McArthur E; Battistella M; Garg AX; Sood MM; Brimble KS
PLoS One; 2020; 15(8):e0237868. PubMed ID: 32818951
[TBL] [Abstract][Full Text] [Related]
9. Temporal Trends in Polypharmacy and Hyperpolypharmacy in Older New Zealanders over a 9-Year Period: 2005–2013.
Nishtala PS; Salahudeen MS
Gerontology; 2015; 61(3):195-202. PubMed ID: 25428287
[TBL] [Abstract][Full Text] [Related]
10. The Role of Deprescribing in Older Adults with Chronic Kidney Disease.
Triantafylidis LK; Hawley CE; Perry LP; Paik JM
Drugs Aging; 2018 Nov; 35(11):973-984. PubMed ID: 30284120
[TBL] [Abstract][Full Text] [Related]
11. The association between polypharmacy and health-related quality of life among non-dialysis chronic kidney disease patients.
Adjeroh L; Brothers T; Shawwa K; Ikram M; Al-Mamun MA
PLoS One; 2023; 18(11):e0293912. PubMed ID: 37956162
[TBL] [Abstract][Full Text] [Related]
12. Features of anticholinergic prescriptions and predictors of high use in the elderly: Population-based study.
Joung KI; Shin JY; Cho SI
Pharmacoepidemiol Drug Saf; 2019 Dec; 28(12):1591-1600. PubMed ID: 31692168
[TBL] [Abstract][Full Text] [Related]
13. Characterizing Potentially Inappropriate Prescribing of Proton Pump Inhibitors in Older People in Primary Care in Ireland from 1997 to 2012.
Moriarty F; Bennett K; Cahir C; Fahey T
J Am Geriatr Soc; 2016 Dec; 64(12):e291-e296. PubMed ID: 27996115
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of potentially inappropriate prescribing in a subpopulation of older European clinical trial participants: a cross-sectional study.
O Riordan D; Aubert CE; Walsh KA; Van Dorland A; Rodondi N; Du Puy RS; Poortvliet RKE; Gussekloo J; Sinnott C; Byrne S; Galvin R; Jukema JW; Mooijaart SP; Baumgartner C; McCarthy V; Walsh EK; Collet TH; Dekkers OM; Blum MR; Kearney PM
BMJ Open; 2018 Mar; 8(3):e019003. PubMed ID: 29567842
[TBL] [Abstract][Full Text] [Related]
15. [Drug Prescribing for Patients with Chronic Kidney Disease in General Practice: a Cross-Sectional Study].
Mahner M; Raus C; Ludwig F; Weckmann G; Stracke S; Chenot JF
Dtsch Med Wochenschr; 2018 Jun; 143(12):e99-e107. PubMed ID: 29898484
[TBL] [Abstract][Full Text] [Related]
16. How do potentially inappropriate medications and polypharmacy affect mortality in frail and non-frail cognitively impaired older adults? A cohort study.
Porter B; Arthur A; Savva GM
BMJ Open; 2019 May; 9(5):e026171. PubMed ID: 31092652
[TBL] [Abstract][Full Text] [Related]
17. Prescribing quality in secondary care patients with different stages of chronic kidney disease: a retrospective study in the Netherlands.
Smits KP; Sidorenkov G; van Ittersum FJ; Waanders F; Bilo HJ; Navis GJ; Denig P
BMJ Open; 2019 Jul; 9(7):e025784. PubMed ID: 31326925
[TBL] [Abstract][Full Text] [Related]
18. Effects of hyperpolypharmacy and potentially inappropriate medications (PIMs) on functional decline in older patients discharged from acute care hospitals.
Fabbietti P; Ruggiero C; Sganga F; Fusco S; Mammarella F; Barbini N; Cassetta L; Onder G; Corsonello A; Lattanzio F; Di Rosa M
Arch Gerontol Geriatr; 2018; 77():158-162. PubMed ID: 29778885
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of Polypharmacy, Hyperpolypharmacy and Potentially Inappropriate Medication Use in Older Adults in India: A Systematic Review and Meta-Analysis.
Bhagavathula AS; Vidyasagar K; Chhabra M; Rashid M; Sharma R; Bandari DK; Fialova D
Front Pharmacol; 2021; 12():685518. PubMed ID: 34093207
[No Abstract] [Full Text] [Related]
20. Effectiveness of using STOPP/START criteria to identify potentially inappropriate medication in people aged ≥ 65 years with chronic kidney disease: a randomized clinical trial.
Parker K; Bull-Engelstad I; Benth JŠ; Aasebø W; von der Lippe N; Reier-Nilsen M; Os I; Stavem K
Eur J Clin Pharmacol; 2019 Nov; 75(11):1503-1511. PubMed ID: 31359099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
